Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Retinoblastoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
No biomarker
Retinoblastoma
No biomarker
Retinoblastoma
cyclophosphamide
Sensitive: A1 - Approval
cyclophosphamide
Sensitive
:
A1
cyclophosphamide
Sensitive: A1 - Approval
cyclophosphamide
Sensitive
:
A1
BRD4 overexpression
Retinoblastoma
BRD4 overexpression
Retinoblastoma
JQ-1
Sensitive: D – Preclinical
JQ-1
Sensitive
:
D
JQ-1
Sensitive: D – Preclinical
JQ-1
Sensitive
:
D
B4GALNT1 expression
Retinoblastoma
B4GALNT1 expression
Retinoblastoma
CAR-T immunotherapy
Sensitive: D – Preclinical
CAR-T immunotherapy
Sensitive
:
D
CAR-T immunotherapy
Sensitive: D – Preclinical
CAR-T immunotherapy
Sensitive
:
D
PRMT5 overexpression
Retinoblastoma
PRMT5 overexpression
Retinoblastoma
EPZ015666
Sensitive: D – Preclinical
EPZ015666
Sensitive
:
D
EPZ015666
Sensitive: D – Preclinical
EPZ015666
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
